Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Regeneron Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
REGN
Nasdaq
8731
https://www.regeneron.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
- May 3rd, 2024 2:15 pm
Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
- May 3rd, 2024 1:01 pm
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
- May 3rd, 2024 7:10 am
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
- May 3rd, 2024 5:08 am
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
- May 2nd, 2024 8:03 pm
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
- May 2nd, 2024 2:01 pm
Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
- May 2nd, 2024 1:30 pm
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
- May 2nd, 2024 12:32 pm
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
- May 2nd, 2024 12:00 pm
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
- May 2nd, 2024 11:15 am
Regeneron Reports First Quarter 2024 Financial and Operating Results
- May 2nd, 2024 10:30 am
Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
- May 1st, 2024 10:42 am
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
- Apr 30th, 2024 3:20 pm
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
- Apr 30th, 2024 12:47 pm
Down -8.24% in 4 Weeks, Here's Why Regeneron (REGN) Looks Ripe for a Turnaround
- Apr 29th, 2024 1:35 pm
Countdown to Regeneron (REGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
- Apr 29th, 2024 1:16 pm
EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
- Apr 29th, 2024 11:00 am
11 Oversold Growth Stocks to Buy Right Now
- Apr 28th, 2024 10:32 pm
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
- Apr 25th, 2024 3:42 pm
EXEL vs. REGN: Which Stock Is the Better Value Option?
- Apr 25th, 2024 3:40 pm
Scroll